MAPK3 and head and neck cancer: The enhanced expression of IL-1β after GW5074 treatment was related to an increased phosphorylation of MEK1 and ERK1/2, indirectly confirming that activation of EGFR-downstream MEK and ERK affect IFNγ/TNFα induced chemokine secretion in head and neck cancer.